We are live on ! Find out more
CERO

CERo Therapeutics
CERO

Delisted

CERO was delisted on the 30th of October, 2025.

Back to rankings

7 hedge funds and large institutions have $4.82M invested in CERo Therapeutics in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

22% less funds holding

Funds holding: 9 → 7 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

36% less capital invested

Capital invested by funds: $7.49M → $4.82M (-$2.67M)

Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
6
Increased
–
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AVM
Arch Venture Management
Illinois
+$8.08M
2
HH
HSG Holding
Hong Kong
+$839K
3
Jane Street
Jane Street
New York
+$145K
4
BC
Birchview Capital
Vermont
+$67.1K
5
FIA
FNY Investment Advisers
New York
+$55.9K

Top Sellers

Rank Fund Capital Flow
1
MC
Meteora Capital
Florida
-$2.68M
2
MTCM
Mint Tower Capital Management
Netherlands
-$1.55M
3
YCM
Yakira Capital Management
Connecticut
-$1.2M
4
CS
Clear Street
New York
-$601K
5
Walleye Capital
Walleye Capital
New York
-$527K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVM
1
Arch Venture Management
Illinois
$4.43M +$8.08M +722 New
HH
2
HSG Holding
Hong Kong
$202K +$839K +75 New
Jane Street
3
Jane Street
New York
$81.4K +$145K +13 New
BC
4
Birchview Capital
Vermont
$39.8K +$67.1K +6 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$32.5K – – –
KPWS
6
Kestra Private Wealth Services
Texas
$30.7K +$55.9K +5 New
PA
7
Pineridge Advisors
Missouri
$921 – – –
FIA
8
FNY Investment Advisers
New York
$32 +$55.9K +5 New
JP Morgan Chase
9
JP Morgan Chase
New York
$6 – – –
MC
10
Meteora Capital
Florida
– -$2.68M -121 Closed
CF
11
Cantor Fitzgerald
New York
– -$2 -78 Closed
MTCM
12
Mint Tower Capital Management
Netherlands
– -$1.55M -71 Closed
YCM
13
Yakira Capital Management
Connecticut
– -$1.2M -54 Closed
CS
14
Clear Street
New York
– -$601K -27 Closed
Walleye Capital
15
Walleye Capital
New York
– -$527K -24 Closed
WRBC
16
W.R. Berkley Corp
Connecticut
– -$519K -24 Closed
Walleye Trading
17
Walleye Trading
New York
– -$297K -13 Closed
PCM
18
PenderFund Capital Management
British Columbia, Canada
– -$1.48K – –

CERO Hedge Fund Activity: Q1 2024 in Review

7 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics (CERO) for Q1 2024, worth a combined $4.82M — down 36% from $7.49M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of CERO and 6 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Arch Venture Management, opening a new position worth an estimated $8.08M. The largest seller was Meteora Capital, exiting entirely with an estimated $2.68M sold.

  • 7 institutional investors held CERo Therapeutics (CERO) as of Q1 2024, down from 9 in Q4 2023.
  • Funds reported $4.82M of CERo Therapeutics stock for Q1 2024, down 36% quarter-over-quarter.
  • 6 funds opened new CERo Therapeutics positions in Q1 2024 and 8 closed out, a net change of -2 holders.
  • The largest CERo Therapeutics buyer in Q1 2024 was Arch Venture Management, an estimated $8.08M added.
  • The largest CERo Therapeutics seller in Q1 2024 was Meteora Capital, an estimated $2.68M sold.

Based on aggregated 13F filings for Q1 2024.